EVH EVH エボレント・ヘルス



symbol EVH
会社名 Evolent Health Inc (EVH エボレント・ヘルス)
業種 先端医療機器_テクノロジ―   工業(Industrials)
概要 事業概要 エボレント・ヘルス(Evolent Health Inc.)は医療の提供と支払いに従事する会社である。同社は価値ベースのケアおよび人口の健康管理への移行において、保健システムおよび医師団体を支援する。同社はプロバイダー向けのエンドツーエンドのテクノロジー対応サービスプラットフォームを提供する。技術・プロセス・統合サービスによって強化された同社のプラットフォームによって、プロバイダーが個別報酬(FFS)払い戻しからバリューベースの支払いモデルに報酬を与える支払いモデルに移行することを可能にする。同社のサービスには、人口管理プラットフォーム、データと分析機能の統合、薬局給付管理(PBM)サービス、包括的な保健計画管理サービスなど、顧客に提供するサービスが含まれる。その価値に基づく操作はIdentifiによって権限を与えられ、サポートされる。Identifiは、データを集約・分析し、ケアワークフローを管理し、患者を関与させる同社のテクノロジープラットフォームである。  エボレント・ヘルスは米国のヘルスケア関連持株会社。子会社を通じ、ヘルスケア関連のソフトウエアやコンサルティングサ―ビスを提供する。支払い関連システムに注力し、顧客の価値観に基づいた支払いモデルを構築する。同社は2011年に創立され、米国全土で事業を展開する。本社所在地はバ―ジニア州ア―リントン。  Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care management, and administrative simplification. Evolent serves a national base of leading payers and providers, is the first company to receive the National Committee for Quality Assurance's Population Health Program Accreditation, and is consistently recognized as a top place to work in health care nationally.
本社所在地 800 N. Glebe Road Suite 500 Arlington VA 22203 USA
代表者氏名 Frank John Williams
代表者役職名 Chairman of the Board Chief Executive Officer
電話番号 +1 571-389-6000
設立年月日 41974
市場名 NYSE(ニューヨーク証券取引所)
従業員数 3800人
url www.evolenthealth.com
EBITDA EBITDA(百万ドル) -1.81400
時価総額 時価総額(百万ドル) 1038.68200
売上高 売上高(百万ドル) 627.06300
企業価値(EV) 企業価値(EV)(百万ドル) 1031.40300
当期純利益 当期純利益(百万ドル) -52.95800
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Evolent Health Inc revenues increased 44% to $627.1M. Net loss before extraordinary items decreased 13% to $53M. Revenues reflect Platform and operations services increase of 23% to $500.2M Transformation services increase of 12% to $32.9M. Lower net loss reflects Other Non Rec. I/E - Non Business Activ. decrease from $400K (expense) to $4.1M (income).



   Evolent Health, IBD Stock Of The Day, Breaks Out Amid Fed Uncertainty  2022/07/06 17:55:45 Investor''s Business Daily
Evolent Health Evolent Health EVH $ 33.40 $1.24 3.9% 218% IBD Stock Analysis EVH formed two cup with handle bases — with buy points at 32.55 and 33.24. Composite Rating 99/99 Industry Group Ranking 56/197 Emerging Pattern Cup with Handle Cup with Handle A positive chart pattern named such because it resembles the outline of a coffee cup with a…
   Shareholder Alert - The M&A Class Action Firm Announces an Investigation of Evolent Health, Inc. - EVH  2022/06/30 21:16:00 Kwhen Finance
   Evolent Health Stock: Healthy Growth, But That Is About It (NYSE:EVH)  2022/06/30 13:44:12 Seeking Alpha
Evolent Health (EVH) has been doing quite alright in a tumultuous market here. See why I feel that the risk-reward situation is not compelling enough in EVH.
   Why Evolent Health Stock Crept Higher Today  2022/06/29 22:07:43 The Motley Fool
Investors had a muted, yet positive, reaction to news of the company''s latest acquisition.
   Evolent Health to acquire IPG; reaffirms Q2 and FY22 guidance  2022/06/29 05:52:29 Seeking Alpha
Evolent Health (EVH) to acquire Georgia-based IPG, a leading technology and services company providing surgical management solutions for musculoskeletal conditions, from TPG Growth for…
   Evolent Health ''Notification Award'' Removes $82M Overhang, Notes Piper Sandler  2022/03/07 18:05:34 Benzinga
In an SEC filing , Cook County named Evolent Health Inc (NYSE: EVH ) the sole third-party administrator for CountyCare Health Plan from fiscal 2023 through fiscal 2025. Piper Sandler analyst Jessica Tassan notes that the award extends a contract Evolent has held since … Full story available on Benzinga.com
   Evolent Health to Participate in Upcoming Investor Conferences  2022/03/03 22:00:00 PR Newswire
WASHINGTON, March 3, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Financial Officer John Johnson and Vice President, Investor…
   Evolent Health, Inc. 2021 Q4 - Results - Earnings Call Presentation  2022/02/28 05:28:37 Seeking Alpha
   Evolent Health powers ahead with strong outlook  2022/02/24 15:19:50 Seeking Alpha
Evolent Health <> has added more than a tenth on Thursday morning hours to record the biggest intraday gain since July 2020. Read about the reason.
   Lantheus, Evolent top healthcare gainers; Orphazyme, Rhythm lead losers'' pack  2022/02/24 15:03:03 Seeking Alpha
Lantheus LNTH +34%. Evolent Health (EVH) +18%. Orphazyme (ORPH) -36%. Rhythm Pharmaceuticals RYTM -24%.
   Evolent Health, Inc. (NYSE:EVH) Given Average Recommendation of Buy by Brokerages  2021/11/07 19:18:41 Dakota Financial News
Evolent Health, Inc. (NYSE:EVH) has earned a consensus recommendation of Buy from the seven ratings firms that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that []
   Canaccord Genuity Boosts Evolent Health (NYSE:EVH) Price Target to $50.00  2021/11/07 12:08:48 Dakota Financial News
Evolent Health (NYSE:EVH) had its price target increased by Canaccord Genuity from $37.00 to $50.00 in a report released on Thursday, The Fly reports. They currently have a buy rating on the technology companys stock. Several other equities research analysts have also recently weighed in on EVH. BTIG Research boosted their price objective on Evolent []
   Zacks: Brokerages Anticipate Evolent Health, Inc. (NYSE:EVH) to Announce -$0.04 EPS  2021/11/05 22:06:41 Dakota Financial News
Equities analysts forecast that Evolent Health, Inc. (NYSE:EVH) will announce ($0.04) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Evolent Healths earnings, with estimates ranging from ($0.04) to ($0.03). Evolent Health posted earnings of ($0.01) per share in the same quarter last year, which []
   Evolent Health, Inc. (NYSE:EVH) Expected to Announce Quarterly Sales of $225.07 Million  2021/11/05 21:30:43 Transcript Daily
Wall Street analysts predict that Evolent Health, Inc. (NYSE:EVH) will post sales of $225.07 million for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Evolent Healths earnings, with the lowest sales estimate coming in at $217.69 million and the highest estimate coming in at $232.93 million. Evolent Health posted sales []
   Piper Sandler Boosts Evolent Health (NYSE:EVH) Price Target to $36.00  2021/11/05 17:24:42 Transcript Daily
Evolent Health (NYSE:EVH) had its target price lifted by Piper Sandler from $30.00 to $36.00 in a research note released on Thursday, The Fly reports. They currently have an overweight rating on the technology companys stock. Several other research firms also recently issued reports on EVH. TheStreet upgraded Evolent Health from a d rating to []

 関連キーワード  (先端医療機器_テクノロジ― 米国株 EVH エボレント・ヘルス EVH )


 twitter  (公式ツイッターやCEOツイッターなど)